Tissue factor - A receptor involved in the control of cellular properties, including angiogenesis

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 334-345

  Chen, J ^a   Bierhaus, A ^a   Schiekofer, S ^a   Andrassy, M ^a   Chen, B ^a   Stern, D M ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Metastasis; Tumor growth; Vasculogenesis; VEGF

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; RECEPTOR; THROMBOPLASTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ANGIOGENESIS; BIOLOGICAL MODEL; BIOLOGY; BLOOD CLOTTING; BLOOD VESSEL WALL; CELL FUNCTION; CELL TYPE; CELL VIABILITY; CELLULAR PARAMETERS; CONFERENCE PAPER; CYTOPLASM; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; LIGAND BINDING; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH; WOUND HEALING;

EID: 0034911743     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616231     Document Type: Conference Paper

References (191)

1. The structural biology of expression and function of tissue factor
2. Biochemistry and physiology of blood coagulation
3. Initiation of coagulation by tissue factor
4. Binding of human factor VII and VIIa to monocytes
5. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis
6. Some thoughts about localization and expression of tissue factor
7. Tissue factor on cells
8. Cellular localization of tissue factor in human breast cancer cell lines
9. Vascular protease receptors: Integrating haemostatis and endothelial cell functions
10. Cellular consequences of the initiation of blood coagulation
11. Cell biology of tissue factor, the principal initiator of blood coagulation
12. Complexity of the early genetic response to growth factors in mouse fibroblasts
13. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor
14. Tissue factor expression in human monocytic cell lines
15. Tissue factor expression during monocyte-macrophage differentiation
16. LPS and cytokine-activated endothelium
17. Induction of tissue factor expression in human monocyte/endothelium cocultures
18. Endothelial-leukocyte adhesion molecules in inflammation and metastasis
19. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock
20. Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells
21. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1
22. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
23. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity
24. Self-regulation of procoagulant events on the endothelial cell surface
25. Mechanisms of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor
26. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-kappa B activation
27. Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall
28. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor
29. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
30. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation
31. Lipopolysaccharide induction of tissue factor expression in rabbits
32. Role of NFkappaB in the mortality of sepsis
33. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide
34. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits
35. Tissue factor mRNa in THP-1 monocyteic cells is regulated at both transcriptional and post-transcriptional levels in response to lipopolysaccharide
36. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line
37. Cultured human endothelial cells generate tissue factor in response to endotoxin
38. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
39. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
40. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE
41. Native and oxidized low density lipo-protein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1
42. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells
43. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress
44. A pathway leading to hypoxia-induced vascular fibrin deposition
45. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia
46. Hypoxia/Hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis
47. Regulation of the tissue factor gene
48. Regulation of the tissue factor gene
49. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts
50. A transcriptional repressor of the tissue factor gene in endothelial cells
51. Lipopolysaccharide induction of gene expression in human monocytic cells
52. Tissue factor expression in vital organs during murine traumatic shock: Role of transcription factors AP-1 and NF-kappaB
53. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation
54. Tissue factor expression by monocytes: Regulation and pathophysiological roles
55. Transcriptional regulation of endothelial cell tissue factor expression during Rickettsia rickettsii infection: Involvement of the transcription factor NF-kappaB
56. Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives
57. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B
58. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B
59. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression
60. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Spl-like transcription factors
61. Tissue factor gene transcription in serum-stimulated fibroblasts is mediated by recruitment of c-Fos into specific AP-1 DNA-binding complexes
62. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients
63. Specificity, diversity, and convergence in VEGF and TNF-(alpha) signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells
64. Lipopolysaccharide induction of THP-1 cells activates binding of c-Jun, Ets, and Egr-1 to the tissue factor promoter
65. Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1
66. Regulation of tissue factor gene expression in human endometrium by transcription factor Sp1 and Sp3
67. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
68. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression
69. Inhibition of tissue factor synthesis by disruption of ERK kinases and PKC signaling pathways in human vascular SMCs
70. Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells
71. Binding of human factor VIIa tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor
72. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active
73. Structural design and molecular evolution of a cytokine receptor superfamily
74. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities
75. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis
76. Differential gene expression in migrating renal epithelial cells after wounding
77. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1
78. Transcriptional regulation of tissue factor expression in human endothelial cells
79. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
80. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: A potential link to accelerated arteriosclerosis
81. Involvement of protein kinase C in Rickettsia rickettsii-induced transcriptional activation of the host endothelial cell
82. Role of PKC z in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression
83. Induction of VEGF Gene Transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes
84. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression
85. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
86. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta
87. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible Roles of SP-1
88. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture
89. Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells
90. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids
91. Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway
92. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
93. Mitogenactivated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells
94. A role for NF-kappaB-dependent gene transactivation in sunburn
95. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression
96. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system
97. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth in factor in human cancer
98. Tissue factor expression during human and mouse development
99. Early embryonic expression of murine coagulation system components
100. Role of tissue factor in embryonic blood vessel development
101. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation
102. Targeted disruption of the murine tissue factor gene results in embryonic lethality
103. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
104. Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain
105. Low levels of tissue factor are compatible with development and hemostasis in mice
106. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
107. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
108. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation
109. Tissue factor signaling
110. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
111. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro
112. Up-regulation of tissue factor expression by platelet-derived growth factor in human vascular smooth muscle cells in culture - Role of mitogen-activated protein kinase and effects of intracellular cyclic AMP
113. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets
114. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas
115. Angiogenesis in cancer and other diseases
116. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis
117. Vascular permeability factor, tumor angiogenesis and stroma generation
118. Wound healing - Aiming for perfect skin regeneration
119. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extra-cellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa × tissue factor-induced signal transduction
120. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression
121. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor
122. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice
123. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors
124. The angiogenic effect of tissue factor on tumours and wounds
125. VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells
126. Tissue factor induces migration of cultured aortic smooth muscle cells
127. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer
128. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis
129. Tissue factor over-expression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis
130. Opposite sorting of tissue factor in human umbilical vein endothelial cells and Madin-Darby canine kidney epithelial cells
131. Polar expression of tissue factor in human umbilical vein endothelial cells
132. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells
133. Functional implications of tissue factor localization to cell-cell contacts in myocardium
134. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture
135. Role of tissue factor in metastasis: Functions of the cytoplasmic and extracellular domains of the molecule
136. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis
137. Tissue factor in cancer angiogenesis and metastasis
138. Tissue factor expression in human leukocytes and tumor cells
139. Tissue factor as a tumor procoagulant
140. Immunohistochemical identification of tissue factor in solid tumors
141. Tissue factor expression correlates with histological grade in human pancreatic cancer
142. Expression of tissue factor correlates with grade of malignancy in human glioma
143. Tissue factor expression and angiogenesis in human prostate carcinoma
144. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies
145. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma
146. Urinary tissue factor levels in patients with breast and colorectal cancer
147. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis
148. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis
149. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation
150. Tissue factor expression in normal and abnormal mammary gland
151. Expression of tissue factor in tumor stroma correlates with progression in invasive human breast cancer: Paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family
152. In situ detection of tissue factor in vasculasr endothelial cells: Correlation with the malignant pheno-type of human breast disease
153. Tissue factor expressed in pituitary adenoma cells contributes to the development of vascular events in pituitary adenomas
154. Effect of tissue factor deficiency on mouse and tumor development
155. Tissue factor regulates plasminogen binding and activation
156. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
157. Platelet: Transporter of vascular endothelial growth factor
158. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo
159. Molecular polarity in endothelial cells and tumor-induced angiogenesis
160. Tissue factor expression and metastatic potential of colorectal cancer
161. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis
162. Tissue factor expression in breast tissues: Its correlation with prognosis and plasma concentration
163. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor
164. Tissue factor-initiated thrombin generation activates the signaling thrombin generation activates the signaling thrombin receptor on malignant melanoma cells
165. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation
166. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model
167. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma
168. Tumor infarction by targeting tissue factor to tumor vasculature
169. TNF in the inflammatory response
170. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine
171. Apoptosis is associated with increased cell surface tissue factor procoagulatn activity
172. Regulation of the procoagulant response to arterial injury
173. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface
174. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
175. Tissue factor dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII
176. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa
177. Tissue facor and factor X dependent activation of protease-activated receptor 2 by factor VIIa
178. Factor VIIa-induced p44/42 mitogen-activated protein klinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain
179. Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in culture human nomocytes
180. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor
181. Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction
182. A new paradigm for blood coagulation research
183. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene
184. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism
185. tissue factor cytoplasmic domain peptide is multiple phosphorylated in vitro
186. Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation
187. Chelerythine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin down-regulation in endothelial cells
188. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation
189. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity
190. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface
191. Angiogenesis induced by tissue factor in vitro and in vivo